| |
Randox
have over 20 years experience in the research and manufacture of high quality
diagnostic reagents and equipment for laboratory medicine. Randox is now
firmly implanted as a significant investor in the development of new healthcare
technology solutions.
- Randox
is one of the world’s fastest growing diagnostic companies
- Randox
reinvest circa 30% of our gross income in research and development
- Randox
are the leading British manufacturer of clinical chemistry reagents
- One third
of the workforce is engaged in research and development
- Randox
have the world’s first protein biochip manufacturing facility
- Randox
is a quality assured organisation accredited to standards ISO 9001
- Randox
has won four Queen’s Awards for Export Achievement (1990, 1993, 1997
and 2001)
- RIQAS,
the external quality assessment scheme from Randox is the world’s first
clinical EQA scheme to gain UKAS accreditation
- In 2003,
Randox’s evidence® system won the UK’s premier award for
innovation in engineering (MacRobert Award) from the Royal Academy of
Engineering
- Over the
next three years Randox will be creating over 800 new jobs through a
£123m investment plan, which includes the establishment of ‘The RTD
Centre of Excellence in Proteomics’.
The role
that Randox products play in healthcare decisions is increasing everyday
and our speed of innovation is moving at an unprecedented rate. New diagnostic
solutions with biochip array technology place Randox at the leading edge
of laboratory medicine diagnostics. |
|
